Posters
« Back
Biopharma VS Small Molecules Therapeutic
EP37221
Poster Title: Biopharma VS Small Molecules Therapeutic
Submitted on 05 May 2021
Author(s): Business Development Team
Affiliations: STABICON LIFE SCIENCE
This poster was presented at Stabicon
Poster Views: 152
View poster »


Poster Information
Abstract: Small molecules drug and therapeutic proteins differ substantially in many of their class attributes. At the root of this are their different physiochemical properties, which affect not only the pharmacological aspects of the drug (e.g., mechanism of action, pharmacodynamics(PD), pharmacokinetics(PK),but also safety and efficacy, and even impact product manufacturing/ quality considerations,.Summary: Biopharmaceuticals are protein with considerable therapeutic structural diversity. They tend to be between 100 to 1000 times larger than traditional small molecule drug. Such complex proteins can't be produced using conventional chemical synthesis rather than in a living cell under stringently controlled condition .References: https://www.stabicon.com/blog/Report abuse »
Questions
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters


Unified approach for in vitro data based parameters estimation
Veronika Musatova, Oleg Demin, Svetlana Rubina

Ashwagandha
Business Development Team

Liquids Dosage Forms Development
Helen Smith

Moisture Content Determination
Helen Smith

Genome Editing in Plant
Macia